Correlation Between Vaxcyte and Icosavax
Can any of the company-specific risk be diversified away by investing in both Vaxcyte and Icosavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaxcyte and Icosavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaxcyte and Icosavax, you can compare the effects of market volatilities on Vaxcyte and Icosavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaxcyte with a short position of Icosavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaxcyte and Icosavax.
Diversification Opportunities for Vaxcyte and Icosavax
Pay attention - limited upside
The 3 months correlation between Vaxcyte and Icosavax is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Vaxcyte and Icosavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Icosavax and Vaxcyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaxcyte are associated (or correlated) with Icosavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Icosavax has no effect on the direction of Vaxcyte i.e., Vaxcyte and Icosavax go up and down completely randomly.
Pair Corralation between Vaxcyte and Icosavax
If you would invest 6,175 in Vaxcyte on November 9, 2024 and sell it today you would earn a total of 2,727 from holding Vaxcyte or generate 44.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Vaxcyte vs. Icosavax
Performance |
| Timeline |
| Vaxcyte |
| Icosavax |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Vaxcyte and Icosavax Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vaxcyte and Icosavax
The main advantage of trading using opposite Vaxcyte and Icosavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaxcyte position performs unexpectedly, Icosavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icosavax will offset losses from the drop in Icosavax's long position.| Vaxcyte vs. Larimar Therapeutics | Vaxcyte vs. Syndax Pharmaceuticals | Vaxcyte vs. Merus BV | Vaxcyte vs. Sutro Biopharma |
| Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |